UBcare. Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	196,293	190,597	154,041	133,343	111,762	104,804
Other Revenue	-	-	-0	-	-	-0
Revenue	196,293	190,597	154,041	133,343	111,762	104,804
Revenue Growth (YoY)	9.28%	23.73%	15.52%	19.31%	6.64%	-5.46%
Cost of Revenue	96,247	95,358	73,409	65,820	52,955	48,476
Gross Profit	100,046	95,239	80,632	67,523	58,807	56,328
Selling, General & Admin	83,835	83,850	71,109	57,632	46,086	41,628
Research & Development	2,360	1,617	1,663	289.26	-	-
Amortization of Goodwill & Intangibles	1,440	1,434	1,344	1,208	1,073	1,074
Other Operating Expenses	517.11	518.93	530.29	282.51	340.34	227.14
Operating Expenses	91,312	90,307	77,186	60,308	49,152	43,511
Operating Income	8,734	4,932	3,446	7,215	9,654	12,817
Interest Expense	-1,462	-1,471	-720.45	-379.79	-255.18	-59.93
Interest & Investment Income	704.54	824.12	1,159	1,258	888.31	324.34
Earnings From Equity Investments	37,535	-1,046	-3,659	-3,449	1,338	-5,111
Currency Exchange Gain (Loss)	27.21	64.36	77.61	-803.98	-	0.61
Other Non Operating Income (Expenses)	-1,271	-2,316	1,384	189.77	29.96	-153.96
EBT Excluding Unusual Items	44,267	987.81	1,687	4,029	11,656	7,816
Gain (Loss) on Sale of Investments	60.86	39.93	330.48	3,050	283.98	826.14
Gain (Loss) on Sale of Assets	85.62	29.27	90.62	32.81	7,323	-6.39
Asset Writedown	-66.64	-0.03	-297.87	-219.52	-3,421	-
Other Unusual Items	-	-	130.38	-	-	-
Pretax Income	44,347	1,057	1,941	6,892	15,842	8,636
Income Tax Expense	2,115	2,623	1,748	1,985	3,089	2,290
Earnings From Continuing Operations	42,232	-1,566	193.06	4,908	12,753	6,346
Earnings From Discontinued Operations	-	-	-1,154	-800.55	861.35	503.19
Net Income to Company	42,232	-1,566	-961.23	4,107	13,614	6,849
Minority Interest in Earnings	-1,335	-20.53	-750.45	-521.25	-302.96	-614.74
Net Income	40,897	-1,586	-1,712	3,586	13,312	6,234
Net Income to Common	40,897	-1,586	-1,712	3,586	13,312	6,234
Net Income Growth	-	-	-	-73.06%	113.52%	-8.28%
Shares Outstanding (Basic)	51	51	51	51	51	51
Shares Outstanding (Diluted)	51	51	51	51	51	51
Shares Change (YoY)	-	-	-	-	-	-0.89%
EPS (Basic)	805.97	-31.26	-33.73	70.67	262.33	122.86
EPS (Diluted)	805.97	-31.26	-33.73	70.67	262.33	122.86
EPS Growth	-	-	-	-73.06%	113.52%	-7.46%
Free Cash Flow	10,126	-1,518	1,155	2,695	7,529	9,764
Free Cash Flow Per Share	199.55	-29.91	22.77	53.12	148.38	192.43
Dividend Per Share	30.000	30.000	60.000	60.000	40.000	50.000
Dividend Growth	-50.00%	-50.00%	-	50.00%	-20.00%	-
Gross Margin	50.97%	49.97%	52.34%	50.64%	52.62%	53.75%
Operating Margin	4.45%	2.59%	2.24%	5.41%	8.64%	12.23%
Profit Margin	20.84%	-0.83%	-1.11%	2.69%	11.91%	5.95%
Free Cash Flow Margin	5.16%	-0.80%	0.75%	2.02%	6.74%	9.32%
EBITDA	16,513	12,472	8,831	11,044	12,904	15,164
EBITDA Margin	8.41%	6.54%	5.73%	8.28%	11.55%	14.47%
D&A For EBITDA	7,779	7,540	5,385	3,830	3,250	2,347
EBIT	8,734	4,932	3,446	7,215	9,654	12,817
EBIT Margin	4.45%	2.59%	2.24%	5.41%	8.64%	12.23%
Effective Tax Rate	4.77%	248.12%	90.05%	28.79%	19.50%	26.52%
Advertising Expenses	-	2,318	1,975	1,443	1,844	619.44

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.